NCT07042711View on ClinicalTrials.gov

Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 10, 2025

Primary Completion Date

December 9, 2025

Study Completion Date

December 9, 2025

Conditions
Nasopharyngeal Cancinoma (NPC)
Interventions
DIETARY_SUPPLEMENT

Placebo

Patients are given capsules that can contain either a placebo or Vitamin D.

DIETARY_SUPPLEMENT

Vitamin D 5,000IU Oral Tablet

Patients are given capsules that can contain either a placebo or Vitamin D.

Trial Locations (1)

10430

Dr Cipto Mangunkusumo Hospital and Dharmais Cancer Hospital, Jakarta

All Listed Sponsors
lead

Indonesia University

OTHER

NCT07042711 - Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients | Biotech Hunter | Biotech Hunter